ARO-C3
AROC3-1001
Phase 2 small_molecule completed
Quick answer
ARO-C3 for C3 Glomerulopathy is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- C3 Glomerulopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed